Use of milrinone to support therapy-induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high-risk FLT3+ acute myeloid leukemia

Pediatr Blood Cancer. 2023 Oct;70(10):e30542. doi: 10.1002/pbc.30542. Epub 2023 Jul 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Child
  • Heart Failure* / chemically induced
  • Heart Failure* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute* / therapy
  • Milrinone / therapeutic use
  • Mutation
  • Prognosis
  • fms-Like Tyrosine Kinase 3

Substances

  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3
  • Milrinone